跳至主要内容
临床试验/JPRN-UMIN000000594
JPRN-UMIN000000594已完成4 期

A multicenter open-label trial of entecavir treatment for chronic hepatitis B and cirrhosis: Effectiveness and safety - Entecavir open trial of chronic hepatitis B and cirrhosis

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 65 人开始时间: 2007年8月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
65

研究概览

简要总结

Kobashi H, Miyake Y, Ikeda F, Yasunaka T, Nishino K, Moriya A, Kubota J, Nakamura S, Takaki A, Nouso K, Yamada G, Yamamoto K. Long-term outcome and hepatocellular carcinoma development in chronic hepatitis B or cirrhosis patients after nucleoside analog treatment with entecavir or lamivudine. Hepatology Research 2011 May;41(5):405-16.

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) The patient who has an allergy against nucleios(t)ide analogues. (2) Pregnant women, or the women who are nursing.(3) The patients with an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia).(4) The patients with serious chronic renal failure, or chronic respiratory failure.(5) The patient who was thought to be inappropriate for the study by the doctor.

研究者

发起方
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences

相似试验